As a major component of triglyceride-rich lipoproteins (TRL), apolipoprotein CIII (apoCIII) is considered to participate in the process of CHD by disturbing lipids lipolysis and promoting inflammation response [10–12]. Here, APOC3 is linked to coronary artery disorder.